Active	Status	Sponsor type	Region	Phase	Filter
5 Active 15 Inactive 20 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Uhde, Thomas W
NCT05156047: A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia	Completed	3	214	US	Pitolisant Oral Tablet, Placebo oral tablet	Harmony Biosciences, LLC	Idiopathic Hypersomnia	08/23	08/23
SUVN-G3031, NCT04072380: A Study to Evaluate Safety, and Efficacy of (Samelisant) in Patients With Narcolepsy With and Without Cataplexy	Completed	2	190	Canada, US	SUVN-G3031, Samelisant, Placebo	Suven Life Sciences Limited	Narcolepsy	06/23	06/23
NCT05668754: Placebo-Controlled, Double-Blind, Study to Determine the Safety and Efficacy of SDX in Patients With IH	Active, not recruiting	2	48	US	Serdexmethylphenidate, SDX, Placebo	Zevra Therapeutics, Rho, Inc.	Idiopathic Hypersomnia	06/24	06/24
Donovan, Jennifer L
No trials found